Park Young-sun, Minister of SMEs and Startups (first from the left), visited Solgent located in Yuseong-gu, Daejeon on the 9th to hear about on-site difficulties from the company representatives and other related personnel.

Park Young-sun, Minister of SMEs and Startups (first from the left), visited Solgent located in Yuseong-gu, Daejeon on the 9th to hear about on-site difficulties from the company representatives and other related personnel.

View original image


[Asia Economy Reporter Kim Daeseop] On the 9th, the Ministry of SMEs and Startups announced that it visited Solgent, a company granted emergency use authorization for COVID-19 diagnostic kits.


On this day, Minister Park Young-sun of the Ministry of SMEs and Startups visited the Solgent Research Institute located in Yuseong-gu, Daejeon, to listen to on-site difficulties. Representatives from the Korea Bio Association and Solgent, including its CEO, proposed ▲government support for overseas exports of COVID-19 diagnostic kits ▲continued support for domestic in vitro diagnostic companies to prepare for new infectious diseases.


Solgent is a molecular diagnostic kit manufacturer established in 2000. It develops and produces both reagents and molecular diagnostic kits independently.


Minister Park Young-sun stated, "The relatively low fatality rate of COVID-19 in our country compared to other countries is due to rapid and accurate diagnosis based on the technological capabilities of bio venture companies," adding, "We will spare no support for exports and technology development for bio venture companies fighting against COVID-19."



Minister Park emphasized, "COVID-19 is no longer a domestic issue but a serious threat faced by all humanity. It is necessary to rapidly disseminate and spread our companies' outstanding diagnostic technologies."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing